IPPRA / Grant Monitor

2026-09-06
3129Open opportunities
23IPPRA ≥ 60
0Not yet characterized
580Awaiting detail
2026-09-05Last fetch
Lens
Deadline
Score
Funds
Topic
Category
IPPRA fit Opportunity Topics Ceiling Posted Closes Days
22 High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) RFA-DA-25-060 · National Institutes of Health · applied research biomedical clinical public health mental behavioral health $1,500,000 2024-01-17 2027-03-05 180
18 Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) PAR-25-100 · National Institutes of Health · applied research public health biomedical clinical mental behavioral health 2024-12-06 2027-05-07 243
18 Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) PAR-26-001 · National Institutes of Health · applied research public health biomedical clinical mental behavioral health 2024-11-21 2027-05-07 243
18 Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) PAR-25-317 · National Institutes of Health · applied research public health mental behavioral health social services 2024-12-13 2027-05-08 244
18 BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) RFA-MH-26-140 · National Institutes of Health · applied research biomedical clinical mental behavioral health ai data science 2024-10-23 2027-06-15 282
12 Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required) PAR-24-329 · National Institutes of Health · applied research public health biomedical clinical mental behavioral health 2025-01-08 2027-03-16 191
5 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) PAR-24-293 · National Institutes of Health · applied research biomedical clinical mental behavioral health computing communications 2024-10-01 2027-08-18 346

7 OF 7 ROWS